<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharmiva Signs New Agreement For Resale Of Vernivia]]></title><description><![CDATA[<p dir="auto">BRIEF-Pharmiva Signs New Agreement For Resale Of Vernivia<br />
9:05 Dec 2 (Reuters) - PHARMIVA AB (PUBL) :<br />
SIGNED ANOTHER AGREEMENT FOR RESALE OF PHARMIVA'S<br />
ANTIBIOTIC-FREE SELF-CARE TREATMENT VERNIVIA, WHICH CURES<br />
BACTERIAL VAGINOSIS<br />
PRODUCT IS PLANNED IN THE CUSTOMER'S PHARMACY RANGE FOR<br />
STORES<br />
DURING THE FIRST HALF OF 2022<br />
THE AGREEMENT SIGNIFIES A COMMERCIAL MILESTONE FOR<br />
PHARMIVA,<br />
WHICH CAN OFFER VERNIVIA VIA THREE OF SWEDEN'S FIVE LARGEST<br />
PHARMACY CHAINS</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/443382/pharmiva-signs-new-agreement-for-resale-of-vernivia</link><generator>RSS for Node</generator><lastBuildDate>Fri, 03 Jul 2026 12:20:25 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/443382.rss" rel="self" type="application/rss+xml"/><pubDate>Thu, 02 Dec 2021 08:03:15 GMT</pubDate><ttl>60</ttl></channel></rss>